Although HYAL-1 expression has been shown to be decreased in a few cancer types, in several cancer systems, levels of HYAL-1 and other associated HA-family of molecules, as well as presence of low molecular mass HA fragments generated by HYAL-1, have been shown to correlate with disease progression [16–25]. The gene discussed is HYAL1; the disease is cancer.